Literature DB >> 23665993

Regulation of bcl-2 transcription by estrogen receptor-α and c-Jun in human endometrium.

Zhong-Lian Li1, Ken Ueki, Koji Kumagai, Ryoji Araki, Yoshinori Otsuki.   

Abstract

The estrogen-estrogen receptor (ER) signaling pathway plays crucial physiologic roles in not only the control of reproduction, but also in the generation of cancer in the breast and uterus. While some ER target genes have been identified containing the estrogen-responsive element (ERE), others are activated eventually by ER via protein-protein interaction without binding to ERE. In a previous study, we identified that the proliferative phase-specific expression of the bcl-2 gene in glandular cells could be regulated by the binding of c-Jun to its motifs in the promoter. Results from our present study indicate that the menstrual cyclic expression of bcl-2 could be controlled by either direct binding of ERα to ERE in the c-Jun promoter or the interaction of ERα with c-Jun that binds to its motifs in the bcl-2 gene. Intriguingly, the transcriptionally active form of c-Jun phosphorylated at Ser63 was identified binding to its motifs in the bcl-2 gene in a menstrual cyclic non-specific manner. Our study revealed a novel mechanism that transcriptionally regulates the expression of bcl-2 in the normal human endometrium.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23665993     DOI: 10.1007/s00795-013-0043-y

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  34 in total

1.  Identification of c-Jun as bcl-2 transcription factor in human uterine endometrium.

Authors:  Z L Li; H Abe; K Ueki; K Kumagai; R Araki; Y Otsuki
Journal:  J Histochem Cytochem       Date:  2003-12       Impact factor: 2.479

2.  Differential ligand activation of estrogen receptors ERalpha and ERbeta at AP1 sites.

Authors:  K Paech; P Webb; G G Kuiper; S Nilsson; J Gustafsson; P J Kushner; T S Scanlan
Journal:  Science       Date:  1997-09-05       Impact factor: 47.728

3.  The jun proto-oncogene is positively autoregulated by its product, Jun/AP-1.

Authors:  P Angel; K Hattori; T Smeal; M Karin
Journal:  Cell       Date:  1988-12-02       Impact factor: 41.582

4.  Low oestrogen receptor alpha expression in normal breast tissue underlies low breast cancer incidence in Japan.

Authors:  J S Lawson; A S Field; S Champion; D Tran; H Ishikura; D Trichopoulos
Journal:  Lancet       Date:  1999-11-20       Impact factor: 79.321

Review 5.  The regulation of AP-1 activity by mitogen-activated protein kinases.

Authors:  M Karin
Journal:  J Biol Chem       Date:  1995-07-14       Impact factor: 5.157

6.  A reinvestigation of the multisite phosphorylation of the transcription factor c-Jun.

Authors:  Simon Morton; Roger J Davis; Ann McLaren; Philip Cohen
Journal:  EMBO J       Date:  2003-08-01       Impact factor: 11.598

7.  Epidermal growth factor stimulates transcription of the c-jun proto-oncogene in rat fibroblasts.

Authors:  B Quantin; R Breathnach
Journal:  Nature       Date:  1988-08-11       Impact factor: 49.962

8.  Casein kinase II is a negative regulator of c-Jun DNA binding and AP-1 activity.

Authors:  A Lin; J Frost; T Deng; T Smeal; N al-Alawi; U Kikkawa; T Hunter; D Brenner; M Karin
Journal:  Cell       Date:  1992-09-04       Impact factor: 41.582

9.  C-fos and c-jun expression in human endometrium and myometrium.

Authors:  A Salmi; F M Rutanen
Journal:  Mol Cell Endocrinol       Date:  1996-03-25       Impact factor: 4.102

Review 10.  Causation and prevention of solely estrogen-induced oncogenesis: similarities to human ductal breast cancer.

Authors:  Jonathan J Li; Sara Antonia Li
Journal:  Adv Exp Med Biol       Date:  2003       Impact factor: 2.622

View more
  4 in total

1.  The elevated activation of NFκB and AP-1 is correlated with differential regulation of Bcl-2 and associated with oral squamous cell carcinoma progression and resistance.

Authors:  Manzar Alam; Tanushree Kashyap; Kamdeo K Pramanik; Abhay K Singh; Siddavaram Nagini; Rajakishore Mishra
Journal:  Clin Oral Investig       Date:  2017-02-23       Impact factor: 3.573

2.  Activation of estrogen receptor α by estradiol and cisplatin induces platinum-resistance in ovarian cancer cells.

Authors:  Sohei Matsumura; Tsuyoshi Ohta; Keiko Yamanouchi; Zhiyang Liu; Takeshi Sudo; Takanobu Kojimahara; Manabu Seino; Megumi Narumi; Seiji Tsutsumi; Toshifumi Takahashi; Kazuhiro Takahashi; Hirohisa Kurachi; Satoru Nagase
Journal:  Cancer Biol Ther       Date:  2016-09-30       Impact factor: 4.742

3.  Prenatal Exposure to Triclocarban Impairs ESR1 Signaling and Disrupts Epigenetic Status in Sex-Specific Ways as Well as Dysregulates the Expression of Neurogenesis- and Neurotransmitter-Related Genes in the Postnatal Mouse Brain.

Authors:  Agnieszka Wnuk; Joanna Rzemieniec; Karolina Przepiórska; Bernadeta Angelika Pietrzak; Marzena Maćkowiak; Małgorzata Kajta
Journal:  Int J Mol Sci       Date:  2021-12-04       Impact factor: 5.923

4.  Immunoexpression of DNA fragmentation factor 40, DNA fragmentation factor 45, and B-cell lymphoma 2 protein in normal human endometrium and uterine myometrium depends on menstrual cycle phase and menopausal status.

Authors:  Tomasz Banas; Kazimierz Pitynski; Krzysztof Okon; Marcin Mikos; Aleksandra I Czerw; Andrzej Deptała; Artur Ludwin
Journal:  Arch Med Sci       Date:  2017-07-31       Impact factor: 3.318

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.